The current practice of stroke prevention was assessed respondents reporting treating elevated systolic, diastolic and isolated systolic pressures respectively, in among UK general practitioners (GPs) using a postal questionnaire. A random sample of 583 GPs (response accord with the British Hypertension Society (BHS) guidelines for patients aged 70-79 years. Thresholds for rate 60%) in practice throughout the UK was examined. Main outcomes were the reported practice in the identiblood pressure (BP) treatment in older patients did not differ by region but were higher among respondents fication of stroke risk, management of hypertension, and use of other interventions (particularly aspirin who had been in general practice for more than 10 years. The value of aspirin in preventing stroke in treatment) to reduce the risk of stroke. Most respondents (451, 77%) reported that they specifically identpatients with pre-existing cardiovascular disease was recognized by almost all (560, 96%) respondents. The ified patients at high risk of stroke. However, of these only 301 (67%) used more than one major risk factor to results suggest that there is scope for increasing the benefits of stroke prevention in primary care, by focusdo this and less than one-third used either age or preexisting cardiovascular disease as an indicator. Threshing on the management of patients at high absolute risk, in whom the greatest treatment benefits are likely to olds for drug treatment of hypertension increased markedly with patient age with only 68%, 23% and 9% of be obtained.
Introduction
notably older subjects. This evidence is particularly Despite a gradual fall in incidence, stroke remains strong for hypertension, in which the absolute benethe third most important cause of death in the UK, fits of treatment are greater in older patients, [13] [14] [15] [16] and being responsible for some 80 000 deaths each year the number of patients needing to be treated to prein England and Wales alone.
1 Stroke is also responvent a given number of cardiovascular events are sible for a considerable burden of morbidity, 2 and is correspondingly smaller. 9, 17 The trial results have a key priority for preventive action by the Health led the British Hypertension Society (BHS) to recof the Nation; 3 both population-based strategies, and ommend antihypertensive treatment up to the age of strategies targeting high risk individuals have been 80 years, with diastolic treatment thresholds for advocated. 4 Stroke is particularly well suited to the older patients lower than those in younger latter, as cases are strongly concentrated among patients. 18 The benefit of aspirin in preventing carthose with major risk factors, particularly hypertendiovascular events is greatest in subjects with presion and cigarette smoking. 5, 6 Using a simple scoring existing cardiovascular disease. 10 Similarly, the system based on age, current cigarette smoking, absolute benefits of giving up smoking on stroke risk blood pressure (BP) and pre-existing cardiovascular are greatest in those at high risk, particularly those disease, it is possible to identify a subgroup of onewith hypertension. 12 fifth of the middle-aged population in which more Effective prevention of stroke based on individthan 80% of stroke cases during a 5-year follow-up uals at high risk therefore depends on the effective period will occur. 7 Moreover, there is good evidence and efficient identification and management of these that stroke risk can be reduced in middle age and subjects, particularly in primary care. However, beyond by medical interventions, particularly the little is known about the extent to which doctors treatment of hypertension, 8, 9 the use of aspirin 10 and identify individuals at high stroke risk, and about the cessation of cigarette smoking. 11, 12 The absolute current patterns of risk management, particularly in benefits of these interventions appear to be greater in older patients. We have therefore conducted a nationwide survey of general practitioners (GPs) to 186 further 8%). Practices were categorised by respon-
Materials and methods
dents as being urban (47%), rural (17%), and Ethical approval for this investigation was obtained mixed (36%). from the Ethical Committee of the Royal College of General Practitioners. Subjects were drawn from a Identification of patients at risk of stroke database of doctors, maintained by Walsh Mander Ltd, Rugby. The full data-set includes all UK docFour hundred and fifty-one respondents (77%) tors, is continuously updated, and includes all docreported that they made special efforts to identify tors registered with the GMC. We mailed a random people at high risk of stroke in their normal practice. sample of 1000 doctors obtained from this database, Among those who did so, 376 (83%) reported using who were working in general practice. This BP as an indicator of risk and 290 (64%) cigarette included full and part-time practitioners, principals, smoking. Other important markers of risk were less trainees and assistants, currently working in Great frequently used. Pre-existing cardiovascular disease Britain and Northern Ireland. Our study population was used by 89 (20%) and age by only 3 (1%). Famshowed no significant differences from relevant ily history however, was used as an indicator of risk Department of Health figures for age, geographic by 258 (57%) and obesity by 94 (21%). Nearly all location or sex of doctor.
(431, 95.6%) of those who reported making special Between September and December 1993 (ie, at efforts to identify stroke risk reported using two or least 6 months after publication of the most recent more factors to identify subjects at high risk. How-BHS guidelines on hypertension management), 18 all ever, only 301 (67%) reported using two or more of subjects were sent a detailed questionnaire enquirthe most powerful risk factors (age, BP, cigarette ing about their clinical practice in areas relevant to smoking and pre-existing cardiovascular disease). stroke prevention. They were asked whether they
Respondents were asked to estimate the increase in identified patients at high risk of stroke, and, if so, relative risk associated with the presence of hyperwhich factors they used to do this. They were asked tension and cigarette smoking. Of 580 respondents about their practice in BP management, including answering the question, 204 (35%) of respondents their thresholds for initiating treatment of BP in difcorrectly identified the increase in risk as eight-fold ferent age-groups. Enquiry was also made about or greater, while 65% underestimated the combined their use of other measures to reduce stroke risk, and effect of the risk factors or were unsure. about their views on the potential for improvement of stroke prevention in their practice. Finally, subManagement of high BP jects were asked their age, qualifications, the length of time they had been in general practice and the Aspects of BP management are summarized in Table  location of their practice (rural, urban or 1. Almost half (251, 43%) of respondents reported intermediate). Non-respondents were sent two writhaving a practice protocol for management of BP; of ten reminders, followed by a short questionnaire these most (219, 87%) found it useful. Most doctors enquiring specifically about BP thresholds for treatreported using both systolic and diastolic pressure ment in different age-groups. For geographical to determine clinical management; among the analysis, practices have been divided into those in remainder, 101 (17%) using diastolic pressure only, southern and northern England, Wales, Scotland and four (1%) using systolic pressure alone. Most and Northern Ireland. Northern England is taken to doctors (497, 85%) indicated that their management include the west Midlands and Trent RHA areas as of women would be identical to that in men. Almost well as all regions to the north; on this basis the all said that they would use non-pharmacological division between northern and southern England measures to reduce BP in the first instance, both in approximates to a line between the Bristol Channel a male patient aged 60 years (579, 99%) and in one and the Wash. Results were analysed using the SPSS aged 75 years (563, 97%). When asked about the statistical package version 6.1. 19 Results have been first-line drug treatment which they used in a man expressed as percentages or as averages, using of 75 years, most of the 571 GPs responding (501, medians where distributions are non-normal. P values for comparisons of frequencies or proportions are based on the results of 2 tests and 2 for trend. geographic location, and sex. In addition, short
Results are based on 583 subjects.
questionnaires were received from 78 subjects (a tors (563, 97%) reported treating diastolic hypertension up to the 70-79 year age-group; and most (499, 86%) reported doing so in patients 80 years and over. Similarly, most doctors (536, 92%) reported treating systolic hypertension when combined with diastolic hypertension in patients up to 79 years, with many (475, 82%) also reporting treatment in patients 80 years and over. However, the proportions reporting treatment for isolated systolic hypertension were lower throughout; 352 respondents (60%) reported treatment at some level in patients up to 79 years and 296 (51%) in older patients. Median thresholds for treatment of BP rose with age, both for diastolic pressure (from 95 mm Hg in patients under 60 years to 100 mm Hg for systolic pressure (from 160 mm Hg in patients under 60 years to 180 mm Hg in patients of 80 years and over) (Figures 1-3) .
The agreement of the BP treatment thresholds reported by respondents with the thresholds specified by the BHS 18 are summarized in Table 2 . For diastolic pressure, almost all respondents reported treating at the recommended threshold in the under 60-year age-group, with a marked fall with increasing patient age. Very few respondents met the more rigorous treatment threshold of 90 mm Hg recommended for patients over 60 years. For systolic pressure, 79% reported treating at the recommended threshold in patients under 60 years; a marked decrease with increasing patient age was apparent. In the case of isolated systolic hypertension, the respondents for patients under 60 years, with a marked fall with increasing age. 88%) advocated diuretic treatment, while 60 (11%) Similar median treatment thresholds were found favoured beta-blockers; 124 (22%) also reported in respondents who returned the short reminder using other agents, particularly ACE inhibitors and questionnaire as those who returned the full quescalcium antagonists. When asked the same question tionnaire (data not presented). about a man aged 60 years, a smaller proportion of the 581 respondents favoured diuretics (332, 57%), while more favoured beta-blockers (218, 38%) and Use of other interventions other agents (195, 34%) .
Reported use of other interventions for reducing the Respondents were asked about thresholds for risk of stroke in a patient aged 75 years is summarpharmacological treatment of BP in different patient ized in Table 3 . Stopping cigarette smoking was the age-groups. The results are presented in Figure 1 intervention most frequently identified, followed by (diastolic pressure), Figure 2 (systolic pressure) and the use of aspirin in patients with pre-existing car- Figure 3 (isolated systolic pressure) . Almost all docdiovascular disease, reduction in weight and reduction in alcohol intake. Treatment of hypercholesterolaemia, the use of aspirin in patients without cardiovascular disease and the use of warfarin for lone atrial fibrillation were less widely supported.
Prospects for improvement of stroke prevention in primary care
Most GPs (358, 61%) considered that there was scope for improvement in the prevention of stroke in their practice. Among these, the most frequently mentioned area was the identification of subjects at high risk of stroke (265, 74%) followed by better risk factor management (190, 54%), and better patient education (117, 20%). Almost half of all respon- be concentrated on those under 60 years of age, Results are based upon 583 GPs. For diastolic pressure both the standard 100 mm Hg and the reduced threshold of 90 mm Hg recommended for patients over 60 years of age are illustrated. aspirin treatment was not affected by any of these factors.
while a further 215 (37%) considered that age was not relevant to the focusing of preventive efforts.
Discussion
This study raises important issues about the identiInfluence of doctor and practice characteristics on fication and management of patients at high risk of results stroke. The representativeness of the results must be The influence of practice and doctor characteristics on reported practice in the identification and mantreated with caution in view of the low response rate. However, the similarity of the BP thresholds agement of stroke risk, particularly patterns of BP management, were examined. Thresholds for treatreported in the short questionnaire sent to nonresponders to those reported in the main survey, do ment of 70 to 79-year-old patients by region are shown in Table 4 . This shows that the region in not suggest that a marked bias is being introduced, at least in the assessment of BP treatment. The which the practice was located had no relation to the proportion of respondents treating BP in differextent to which reported practice in a questionnaire survey represents actual practice must also be conent patient age-groups, or to treatment thresholds. Figures for patients in other age bands yielded simisidered; earlier reports suggest that questionnaire 20 While most respondents reported that they took during the last 4 years in Great Britain 21,23,24 have shown that treatment thresholds increase with special measures to identify patients at risk of stroke, the use of more than one major risk factor patient age. Table 6 summarizes the results of these three surveys in which results are presented in a (particularly age, systolic BP (SBP), cigarette smoking and pre-existing disease) to identify patients at comparable format. This does suggest that median treatment thresholds, particularly in the older high risk was reported by only slightly more than half of respondents overall. The powerful combined patient age-groups, may have declined during this period. Our own findings do not suggest that the effect of high BP and cigarette smoking (associated with an increase in risk of more than eight-fold) was geographic location of practitioners in the different surveys is likely to have been an important influence widely underestimated. In contrast, family history of stroke, a factor with only a weak relationship to on the treatment thresholds observed. However, the practitioners included in these surveys at three timestroke risk, 6 was referred to as an important predictor by more than half of respondents.
points were not the same and interpretation must therefore be cautious. Even if a decline in treatment Evidence of the effectiveness of treatment of elevated BP levels at or above a diastolic threshold of thresholds for older patients has occurred, substantial proportions of respondents were still not meet-100 mm Hg and a systolic threshold of 160 mm Hg up to the age of 80 years is now strong. [13] [14] [15] [16] Relative ing BHS thresholds for treatment of hypertension in the 70-79 year age-group. When taken together with benefits of treatment are maintained at older ages, so that the absolute benefits are greater, and the evidence of the limited extent of recognition, treatment and control of hypertension, 25,26 this suggests number of patients needing to be treated (NNT) to prevent one of stroke or other cardiovascular event that many opportunities for the prevention of stroke and other cardiovascular disease are being missed. are between one-half and one-quarter of those in younger patients. 17 Indeed, this greater absolute There are several possible reasons for the conservative approach to treatment of hypertension in benefit resulted in the BHS recommending a diastolic treatment threshold in older patients, lower older patients. Limited knowledge of the results of recent trials, delay in implementation of changes in than that in younger patients. 18 This evidence contrasts with the results of the present study, which practice, or concerns about increased practice workload may be playing an important part. Alternatively suggest that treatment thresholds rise with patient age. The variation in treatment thresholds with age the conservative approach may reflect some doctors' perceptions that relative risk and relative benefit is more marked for systolic pressure than diastolic pressure, and most marked of all for isolated systolic provide the best guide to treatment, favouring younger patients, 21 or it may reflect concerns about hypertension. For isolated systolic hypertension the paradox is particularly marked. Trial evidence has the side effects of treatment in this age-group. However, there are strong grounds for using absolute risk established the benefit of treatment in patients of 70 years and more at a systolic treatment threshold of and absolute benefit as the best guide to treatment. 22 Moreover, even allowing for the shorter life expect-160 mm Hg. 16 However, the survey results suggest that respondents favour treatment in subjects under ancy of older people, the person years of life gained and disability free life-years gained from treatment 70 years (where there is no trial evidence), rather than in subjects between 70 and 80 years where the of hypertension in patients over 60 years exceed those from treatment in younger groups (Ebrahim S, strongest trial evidence exists. Additionally, despite the observation that treatment thresholds rise with unpublished data). Moreover, the rate of side effects leading to treatment withdrawal in older people is age, many respondents report being prepared to initiate treatment of hypertension in patients above low, particularly when diuretic treatment is used. extent to which this reflects the medical culture in Accurate assessment of absolute stroke risk requires that several risk factors are taken into account simulwhich they trained (strongly hostile to treatment of high BP in older patients) and their practice in taneously, using a risk scoring system. At their simplest such systems can allocate a point for each implementing findings from new research remains uncertain. A further difficulty may be poor access major risk factor, while more sophisticated systems allocate weighted scores to each factor. 7 The first to figures relating to absolute risk, and the number needed to treat (NNT), as many guidelines do not step in ensuring that absolute risk is reflected in the management of stroke risk factors is to ensure that discuss these clearly, or indeed may not provide them at all. 27 The clear presentation that around 50 hypertension in older adults (60-79 years) is identified and managed appropriately. In practice, this patients aged 60-79 years of age can prevent one stroke, 17 may help GPs weigh the effect of high implies that sustained BP levels regarded as indications for treatment in patients under 60 years of absolute risk more appropriately in their treatment decisions.
age (diastolic pressure у100 mm Hg, systolic pressure у160 mm Hg) should also be regarded as treatThe value of aspirin in reducing stroke risk in patients with pre-existing cardiovascular disease, 10 ment indications in the 60-79 year age-group, 18 in patients without serious co-morbidity. 17 These was widely recognized by respondents. Interestingly, a substantial minority of respondents reported changes would be most valuable if coupled with measures to improve the detection and management using aspirin for stroke prevention in patients without cardiovascular disease -a group in whom the of hypertension in general, particularly addressing the 'rule of halves'. 25, 26 These measures would have absolute benefits of aspirin are small and the case for treatment more controversial. 10 The effectiveness important implications for workload in their own right. 26 of anticoagulation in patients with lone atrial fibrillation has been established by clinical trials. 28 HowAttempting to implement a lower diastolic treatment threshold in patients over 60-years-old, than in ever, its implications remain controversial because of the selected nature of the trial populations, and younger patients is probably unrealistic in the short term. Although guidelines on the management of BP because the overall benefits are strongly dependent on haemorrhagic complication rates. 29 The results of in older patients have been published, 9,18 earlier experience suggests that this will not of itself be sufthis study make it clear that the measure is not currently favoured by a majority of GPs -a finding conficient to bring about the changes desired. 32,33 Specific collaboration between the GP and local experts sistent with that of earlier surveys. 30 with an interest in stroke prevention to discuss current practice, and the justification for change is Implications likely to be more helpful in producing the desired changes in practice. Such collaboration can lead to Increasing evidence suggests that cardiovascular prevention in primary care should focus on people the construction of guidelines and implementation plans which, by taking local constraints into at high absolute risk, in whom the absolute benefits from intervention are likely to be greatest. 31 Stroke account and generating a sense of local ownership, are more likely to bring about change. 34, 35 is particularly well suited to such an approach both because of the concentration of risk factors in some subjects, 5, 6 and the evidence for the reversibility of risk by intervention during adult life. [8] [9] [10] [11] [12] In order to vey.
